Koninklijke Philips N.V.

NYSE:PHG

Medical - Devices

Healthcare
$29.81 +2.17%

+$0.57 today

Market cap
$29.11B
Beta
0.93
P/E (TTM)
23.1
EPS (TTM)
$1.02
Dividend yield
3.62%
52W Low $22.20High $33.44

Volume 1.45M

Average 1.17M

PHG Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Koninklijke Philips N.V.NYSE: PHG

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) grows, but more slowly than its trailing trend

Q2 FY2026 weighted avg shares (diluted) of 968.57M shares rose 1.2% year over year, behind the +3.5% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +0.4% a year.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +1.2% toward the trailing-twelve-month pace of +3.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
968.57M+0.0% QoQ
Last fiscal yearDec 2025
962.5M+3.1% YoY
LTMJun 2026
966.72M+3.5% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.2%——
1 year+3.1%——
3-year CAGR+0.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
962.5M EUR
Year-over-year change
+3.1%
4-year CAGR
+0.3%

Weighted Avg Shares (Diluted) vs competitors

How PHG compares with its peers on the latest reported figures

  • PHG's LTM Jun 2026 weighted avg shares (diluted) of 966.72M shares is the 4th highest of the 10 companies compared; the peer median is 436.47M shares.
  • Its year-over-year change of +3.5% is the 2nd highest of 10, against a peer median of +0.0%.
  • Over three fiscal years its annual growth of +0.4% compares with a peer median of +0.5%.
PHG Competitors Peer median
Weighted Avg Shares (Diluted) for PHG and competitors
Company Period LTM YoY 3-year CAGR
ABTAbbott LaboratoriesLTM Sep 20261.74B -0.3%-0.3%
BSXBoston Scientific CorporationLTM Jun 20261.49B +0.1%+1.3%
MDTMedtronic plcLTM Jul 20261.29B +0.0%-1.1%
PHGKoninklijke Philips N.V.LTM Jun 2026966.72M +3.5%+0.4%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026457.07M -0.4%+0.5%
SNNSmith & Nephew plcFY2025436.47M -0.4%-0.1%
RMDResMed Inc.LTM Jun 2026146.52M -0.6%-0.6%
LIVNLivaNova PLCLTM Sep 202656.03M +2.3%+0.6%
NPCENeuroPace, Inc.LTM Mar 202633.11M +10.6%+10.0%
IRMDIRadimed CorporationLTM Mar 202612.86M +0.6%+0.6%
Peer median (excluding PHG) 436.47M+0.0%+0.5%

Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.16B17.83B18.17B18.02B17.83B
Cost of Revenue9.99B10.63B10.72B10.25B9.78B
Gross Profit7.17B7.19B7.45B7.77B8.06B
Gross Margin41.8%40.4%41.0%43.1%45.2%
Research & Development1.81B2.09B1.89B1.75B1.7B
Selling, General & Admin4.86B5.29B5.13B5.07B4.97B
Operating Expenses6.62B8.72B7.56B7.24B6.63B
Depreciation & Amortization1.32B1.6B1.26B1.39B1.13B
EBITDA2B115M1.04B1.85B2.64B
EBITDA Margin11.6%0.6%5.7%10.3%14.8%
Operating Income553M(1.53B)(115M)529M1.42B
Operating Margin3.2%-8.6%-0.6%2.9%8.0%
Interest Income18M25M46M79M108.54M
Interest Expense164M244M306M337M332.34M
Other Income / Expenses(44M)(202M)(412M)(406M)(242M)
Income Before Tax509M(1.73B)(527M)123M1.18B
Pre-Tax Margin3.0%-9.7%-2.9%0.7%6.6%
Income Tax Expense(103M)(113M)(73M)963M282M
Net Income3.32B(1.61B)(466M)(702M)895M
Net Margin19.3%-9.0%-2.6%-3.9%5.0%
EPS (Basic)0.67(1.68)(0.49)(0.75)0.95
EPS (Diluted)0.64(1.68)(0.49)(0.75)0.93
Weighted Avg Shares907.46M952.46M948.79M933.37M962.37M
Weighted Avg Shares (Diluted)950.28M952.46M948.79M933.37M962.5M

Koninklijke Philips N.V.

NYSE:PHG

Intrinsic Alpha fair value

Locked

Current Price

$29.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.